What is the therapeutic role and blood glucose lowering capability of Bromocriptine and Cholestyramine for the treatment of Type 2 diabetes?
Answer from: at Community Practice
In the 15 or so years since bromocriptine and cholestyramine were approved for the treatment of hyperglycemia in T2DM, I have never prescribed them for this indication. I also have very rarely used other FDA-approved glucose-lowering agents including meglitinides, alpha-glucosidase inhibitors and am...
Comments
at Central Coast Endocrinology And Diabetes I do pretty much the same thing but after 25 years...
at UCSF - Fresno I practice very similarly to you, though I will qu...
I do pretty much the same thing but after 25 years...
I practice very similarly to you, though I will qu...